Sales and Marketing

The FDA has updated the Emergency Use Authorisation (EUA) for Regeneron Pharmaceuticals’ COVID-19 antibody cocktail, REGEN-COV, halving the dose from …

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …

Before any kind of new medicine can be made available to the market, it has to go through a strictly …

Softbox Systems has appointed Sean Austerberry as its Research and Product Development Director. Sean will be responsible for all of …

Sharp has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. In early 2019 Mr …

Acacia Pharma has appointed Debra Hussain as Chief Commercial Officer. She is a highly experienced commercial leader having spent over …

Redx Pharma has appointed Natalie Berner as a Non- Executive Director, she will represent RM Special Holdings 3 LLP on …

 

The EMA has approved the Pfizer-BioNTech COVID-19 vaccine for 12-15 year olds. Individual EU member states can now decide if …

A five-month-old baby is one of the first patients to receive Zolgensma, the world’s most expensive drug, on the NHS. …

The US Centers for Disease Control (CDC) is looking in to a small number of reports that some young vaccine …

Ferring Pharmaceuticals and Rebiotix have presented Phase III results demonstrating superior efficacy of investigational RBX2660 in reducing recurrence of Clostridioides …

The FDA have granted accelerated approval of Rybrevant (amivantamab-vmjw) for the treatment of patients with metastatic non-small cell lung cancer …

A new Public Health England (PHE) study shows that two doses of either the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine are …

Bristol Myers Squibb (BMS) has announced follow-up data from their Phase III CheckMate-067 clinical trial, which demonstrated that 49% of …